ARYX — ARYx Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.37m
Annual cashflow statement for ARYx Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28 | -27.3 | -27.6 | -31.2 | -33.2 |
| Depreciation | |||||
| Non-Cash Items | 0.839 | 0.826 | 1 | 2.65 | 2.37 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.13 | 21.5 | -2.16 | -17.7 | -5.25 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -22.4 | -4.21 | -27.7 | -45.2 | -35 |
| Capital Expenditures | -3.85 | -0.962 | -0.499 | -0.644 | -0.141 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 13.4 | -17.6 | 23.9 | -1.77 | 8.55 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 9.53 | -18.5 | 23.4 | -2.41 | 8.41 |
| Financing Cash Flow Items | — | 0 | 0 | 20.4 | -0.092 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.2 | 28.9 | 41.2 | 28.2 | -2.04 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.73 | 6.21 | 36.8 | -19.5 | -28.6 |